275 related articles for article (PubMed ID: 11488184)
21. [Converting enzyme inhibitors in acute myocardial infarct and heart failure].
Arslanagić A; Raljević E
Med Arh; 1999; 53(1):29-31. PubMed ID: 10356928
[TBL] [Abstract][Full Text] [Related]
22. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization.
Lazar HL; Volpe C; Bao Y; Rivers S; Vita JA; Keaney JF
Ann Thorac Surg; 1998 Aug; 66(2):487-92. PubMed ID: 9725390
[TBL] [Abstract][Full Text] [Related]
24. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
25. The effects of ACE inhibition on progression of atherosclerosis.
Sharpe N
J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S9-12. PubMed ID: 7514240
[TBL] [Abstract][Full Text] [Related]
26. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
27. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.
Bertrand ME
Curr Med Res Opin; 2004 Oct; 20(10):1559-69. PubMed ID: 15462689
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
29. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
[TBL] [Abstract][Full Text] [Related]
30. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
31. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
32. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
Yusuf S; Lonn E
Eur Heart J; 1998 Sep; 19 Suppl J():J36-44. PubMed ID: 9796839
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
Tokmakova M; Solomon SD
Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
[TBL] [Abstract][Full Text] [Related]
34. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
35. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
Shah NC; Pringle S; Struthers A
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
[TBL] [Abstract][Full Text] [Related]
36. Vascular protection: current possibilities and future perspectives.
Lüscher TF
Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
[TBL] [Abstract][Full Text] [Related]
38. Impact of imidapril on cardiac mitochondrial function in an ex-vivo animal model of global myocardial ischemia.
Monteiro P; Gala S; Nobre S; Carreira R; Gonçalves LM; Providência LA
Rev Port Cardiol; 2005 Jan; 24(1):53-61. PubMed ID: 15773666
[TBL] [Abstract][Full Text] [Related]
39. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?
Remme WJ
Drugs; 1997; 54 Suppl 5():59-70. PubMed ID: 9429846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
